Deloitte in Switzerland
In today’s environment, companies aren’t just looking to grow, they’re looking to differentiate through innovation. Deloitte offers a full suite of M&A services that can help drive value from acquiring innovation.
We advise both corporate and private equity buyers on M&A transactions across the entire deal life cycle. Our approach is holistic and disciplined, focusing on significant risk issues and key value drivers from the definition and execution of the M&A strategy till the successful integration of the acquisition and delivery of the deal promise.
We are an integrated professional services firm offering experienced accounting, tax, consulting, business modelling, valuation, finance advisory and integration & separation professionals who have a primary focus on Life Sciences M&A. Consistently ranked among the world's leading M&A advisers, Deloitte draws on decades of experience and deep industry knowledge. With one of the largest Life Sciences and Health Care consulting practices in the industry, our specialists are closely connected to the M&A practice and can be brought in to serve our clients throughout the M&A life cycle or provide advice on the operations of their businesses.
Drooms AG is a leading European provider of secure cloud solutions. This software specialist facilitates highly secure access to confidential documents as well as the ability to safely exchange them with third parties beyond company firewalls. Confidential business processes, such as financing and licensing projects or Board Communication are handled securely, transparently and efficiently with Drooms. Headquartered in Frankfurt, Germany´s banking hub, Drooms is also expanding its global market presence and now has offices in Munich, London, Paris, Amsterdam, Zug, Madrid, Milan and Vienna. The company is well positioned to facilitate large-scale local and multi-jurisdictional transactions. Their professional expertise, top-tier reputation and innovative processes have laid the groundwork for a growing reputation in this market space. Selected References include Astellas, Hormosan, HRA Pharma, Novartis, NovImmune SA and Siemens.